“The markets are dead!”: Emerita Resources (EMO.V) shows otherwise with massive upside coming
Lithium Ionic (LTH.V) is up 50% in 3 months, and is moving toward production
Digital Twinning, and how EdgeTI (CTRL.V) is a serious story you’ve never heard of
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
Why Prospera Energy (PEI.V) might be a transformational investment opportunity in Canadian oil & gas
Sparc AI (SPAI.C) completes development of drone advanced target acquisition system
Vancouver media personality, Jody Vance, took time to talk with Medexus Pharmaceuticals (MDP.V) CEO and director Ken d’Entremonet to get a better look at the company’s specialty pharma portfolio and what investors can look forward to over 2021. Tune in!
Full disclosure: Medexus Pharmaceuticals is an Equity.Guru marketing client
